Product Images Alendronate Sodium

The text provides a chart with the cumulative incidence of hip fractures in a three-year study of FIT, comparing the placebo to the drug, Alendronate Sodium. The X-axis represents time in months, while the Y-axis shows the cumulative incidence in percentage. The study was conducted on patients with radiographic vertebral fracture at baseline. No further information is given.*

This is a report on a study in Paget's disease of bone where the effect on serum alkaline phosphatase of Alendronate sodium 40mg/day was compared to placebo or Etidronate 400mg/day. The study had a sample size of 27 and 47 respectively. The report presents a graph of mean % change in serum alkaline phosphatase from baseline for the treatments at varying time intervals (months).*

This is a label for a medication called Alendronate Sodium 35mg produced by NuCare Pharmaceuticals, Inc. It includes information such as lot number, expiration date, and National Drug Code (NDC) numbers. It also recommends that the medication be kept out of reach of children and stored at a controlled temperature. To see a full list of ingredients and for medical advice about side effects, the manufacturer's label should be consulted.*